Results 11 to 20 of about 18,604 (234)
JGH Open, Volume 6, Issue 12, Page 904-909, December 2022., 2022 Classically described in the group of non‐cirrhotic portal hypertension, obliterative portal venopathy (OPV) causes are still unknown. Our aim is to describe the characteristics of 43 OPV patients and potential risk factors. Clinically significant portal hypertension was found in 28% of cases. The most frequent indication for liver biopsy was elevation
Vinícius Nunes +7 more
wiley +1 more source
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
Journal of Investigative Medicine High Impact Case Reports, 2023 COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome.
Lauren Bitterman MD +5 more
doaj +1 more source
Consequences of antiphospholipid syndrome in pregnancy - A review [PDF]
Romanian Journal of Rheumatology, 2023 Background and objectives. Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies (aPL) in the blood.
Astrit M. Gash
doaj +1 more source
Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
Современная ревматология, 2022 Classical serological markers of antiphospholipid syndrome (APS) are antibodies to cardiolipin, antibodies to β2-glycoprotein 1, and lupus anticoagulant.
T. M. Reshetnyak +3 more
doaj +1 more source
Clinical Case Reports, 2023 Key Clinical Message This report described the pathophysiology, diagnostic workup, and management of thrombosis possibly associated with peripheral blood eosinophilia and transient positive antiphospholipid antibodies in the setting of cellulitis ...
Han Naung Tun +5 more
doaj +1 more source
Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers. [PDF]
PLoS ONE, 2017 The non-criteria neuropsychiatric manifestations of antiphospholipid syndrome include headache, dizziness, vertigo, seizure, depression and psychosis. There were still no objective methods qualified to detect the early central nervous system involvement ...
Ting-Syuan Lin +10 more
doaj +1 more source
Haematologica, 2017 Antiphospholipid antibody syndrome is an autoimmune disease characterized by the presence of so-called antiphospholipid antibodies and clinical manifestations such as recurrent thromboembolic or pregnancy complications.
Philippe de Moerloose +5 more
doaj +1 more source
Antiphospholipid Syndrome and Antibodies [PDF]
Journal of Immunology Research, 2014 Antiphospholipid syndrome is an acquired thrombophilia characterized by venous or artery thrombosis sometimes accompanied by thrombocytopenia in the presence of antiphospholipid antibodies. The 14th International Antiphospholipid Antibodies Congress was combined with the 4th Latin American Congress on Autoimmunity and took place in Rio de Janeiro in ...
Jozélio Freire de Carvalho +2 more
openaire +3 more sources
Asian Pacific Journal of Tropical Medicine, 2021 Objective: To describe the prevalence of antiphospholipid antibodies in coronavirus disease-19 (COVID-19) and to find potential associations between antiphospholipid antibody positivity and clinical outcomes.
Cesarius Singgih Wahono +8 more
doaj +1 more source
Annals of Noninvasive Electrocardiology, Volume 28, Issue 1, January 2023., 2023 The patient’s ECG exhibited QT‐interval prolongation with T‐wave inversion in anterior and inferior leads that, together with CT‐pulmonary angiography findings, strongly suggested PE. This ECG pattern is crucial for diagnosing PE. Abstract Even though patients with pulmonary embolism usually present with respiratory distress and tachycardia, the ...
Jing‐Xiu Li +3 more
wiley +1 more source